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INTRODUCTION:
Pain management in Indian scenario for malignant and non-malignant patients are still beyond the scope of majority of patients and remains largely accessible at tertiary cancer centres and handful of dedicated hospice and palliative institutes. [1] The reasons are diverse ranging from poor socioeconomic conditions and poor compliance onus of which lies with patients, to logistics problem of hospitals, non availability of designated palliative and hospice centres and many more. [2] [3] [4] [6] So use of this drug has largely remained elusive to many patients and physicians. The myths of morphine, especially respiratory distress at high doses has restricted the use to low suboptimal doses in both hospitals and in domiciliary set ups. [7] The present study was done to compile the demographic profiles for patients treated with morphine on domiciliary care under the supervision of palliative care centre in a medical college.
MATERIALS AND METHODS:
A prospective longitudinal study was performed between October, 2013 to March, 2016 among patients attending palliative clinic at tertiary care hospital. The palliative care team comprised of radiation oncologists, anaesthetists working with pain clinic, surgeons, a nurse, social workers and a psychologist. The patients recruited in the study were suffering from biopsy or cytology proven malignant conditions with known primary or unknown primary, irrespective of age, all stages, morphine naive, with no known contraindication to morphine and either capable of self care and or under supervision of responsible family member. Raised intracranial tension, severe respiratory distress with history of uncontrolled COPD, bronchial asthma with severe lung impairment and renal and hepatic impairment were contraindications to morphine prescriptions. [8, 9] All patients recruited in study would have to comply with standard guidelines for analgesics prescription.
On day 1, at the palliative clinic, -morphine naive patients‖ and responsible care givers were interviewed. The data were tabulated in predesigned excel chart, which included patients' case history details and specific inputs on analgesics like NSAIDs, non-morphine opioids, and adjuvants. For patients receiving codeine, tramadol prior to recruitment in study, conversion to oral morphine equivalent (OME) was done by -Equianalgesics Opioid Conversion tables‖.
[10] The drug was prescribed after obtaining necessary licence from Narcotic department through our hospital authorities. All patients were asked to take first dose of oral morphine on Day 1 in front of physicians and vital signs were monitored for 1 hour to detect like idiosyncratic respiratory suppression. Telephonic conversions were used to communicate for weekly review of pain, adverse events and any additional data. Patients were re-assessed at monthly intervals. -Visual Analog Scale‖ was used for pain at the beginning and during the study period, however because the treatment comprised of palliative radiation, surgery and polypharmacy, no score was used in statistical analysis for correlation of opioid dose and pain relief. While Edmonton classification is generally used for stratification of maximum total daily morphine dose usage, we had stratified our patients into 3 groups based on Analgesic Quantification Algorithm (AQA) for use of strong opioids: Group A (≤<75mg/day), Group B (> 75 -150 mg/day) and Group C(> 150 -300 mg/day) of Oral Morphine Equivalent (OME) for statistical analysis.
RESULTS:
During October, 2013 to March, 2016, 523 patients were started on oral morphine after fulfilling the requirements of pain treatment protocol. 48.2% of patients were males, in whom the most common cancers were head and neck (32.1%) and lung (27.8%) malignancies. This largely reflects the widespread use of tobacco smoke and tobacco containing chewing elements which remains a large scale public health inspite of anti-tobacco drive by government of India. In 51.8% females patients cervical cancer still predominated as most common cancer (36.2%) followed by breast cancer at 33.2%. (Table 1) 71.9% of patients had evidence of metastases with majority having both bone and visceral involvements (166/523). Palliative radiation (20Gray in 5 fractions, 30Gray in 10 fractions or single fraction of 8Gray) was used in 37.3% patients for bone metastasis, brain metastases, cord compression and superior venal caval obstruction syndrome. 19.3% patients had no use of opioids at the time of recruitment which meant that they were started at level WHO ladder step3 on oral morphine directly for control of severe pain. Codeine and tramadol were commonly used opioids either in single drug formulations or in combinations with NSAIDS. (Table 2 ) Commonly used NSAIDS were ibuprofen (400 -600 mg, QDS) , diclofenac (60mg, QDS) and paracetamol (500mg-1gm, QDS). 15.1% of patients had morphine threshold below 75 mg /day while 26.27% patients had dose in excess of 150 mg/day. (table 3 ) None of the patients received dose > 300mg OME according to AQA. -Breakthrough pain dose‖ was prescribed in all patients, however only 60% of the patients followed the advice. None of the patients had respiratory repression after first dose. The adverse events were not significantly different among the 3 groups of patients. (table 4) DISCUSSION:
The present day health problems in India are shifting from acute illness to chronic illness like cardiovascular diseases, diabetes, cancer, mental diseases and road traffic accidents. The estimated new cancer cases are likely to cross 17.3 lakhs with 8.8 lalkh deaths in 2020.
[11] Inspite of cancer detection and awareness, still 80% of patients would be diagnosed in advanced stages. [12] For majority of these subset of population palliative care might just the appropriate intervention available. Cancer -pathologic‖ pain is further divided into neuropathic, somatic and visceral subtypes. It is very difficult to distinguish the subtypes as considerable overlaps a classic example of which is cord compression due vertebral body metastases. In our study due logistic problems of arranging nerve conduction velocity tests for all patients, distinguishing among pain subtypes was not possible and hence omitted from the data analysis.
Morphine use in cancer patients treated with palliative care has always been an under-reported in India. In an article published in 2009 by Barathi et.al, internal auditing on use of oral morphine for management of severe pain in 20 patients concluded that training of doctors and nurses significantly improved the quality of pain control. The author was of opinion that -breakthrough pain management‖ was an important integral part of morphine dosage and both nurses and doctors were reluctant to use this for fear of overdosing patients might lead to respiratory distress, harm kidneys and cause addiction.
[15] In our study similar problems existed because of logistic issues as well as non-compliance of the patients. Bercovitch et.al in a retrospective study on 435 patients on -homecare hospice service‖ concluded adverse effects were similar with good safety profile in the three groups receiving regular (5-299 mg of morphine per day), high (300-599 mg of morphine per day), and very high doses ( ≥600 mg of morphine per day). The authors concluded domiciliary use of ≥ 300 mg morphine doses was safe and does not adversely affect the patients' life expectancy, hospice team should not be apprehensive of adverse events.
[16]
CONCLUSIONS:
Drawbacks of the study were 1) pain score was not used in statistical analysis, 2) subset analysis of role of morphine for relief in neuropathic and visceral pain was not available because it was difficult to distinguish between them, and 3) due to logistic problems it was not possible for assessing the patients at OPD frequently for dose modifications. Morphine remains the ultimate analgesic for terminally ill cancer patients suffering from severe pain. With no ceiling effect or optimum schedule for morphine dosage, all health personals remain cautious when prescribing the drug.
[17] Our experience from a tertiary medical college definitively goes on to prove that high dose morphine use is safe and efficacious even when used in domiciliary setting control cancer pain. 
